ENZN
Sign in
Enzon Pharmaceuticals Inc
Save
–
Market cap
18x
Current P/E
–
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug.
Similar securities
Based on sector and market capitalization
Report issue